Pharma firm in India to make Russia’s Sputnik V COVID-19 vaccine
MOSCOW:Indian pharmaceutical company Hetero will manufacture over 100 million doses of the Russian Sputnik V COVID-19 vaccine per year under the terms of a deal unveiled on Friday between it and Russia’s RDIF sovereign wealth fund. The move, which RDIF cast as another step in its efforts to scale up international manufacturing of its flagship […]